RXRX vs. SMMT: Two Biotechs, Two Very Different Bets

Life Science

Buffett Indicator Hits All-Time High—What Does History Tell Investors?

Technology

Strategy Ends Six-Year ‘Never Sell’ Bitcoin Streak With $1.25B Plan As Crypto Winter Bites

Cryptocurrency

AeroVironment Surges Nearly 20% After Hours on Blowout Q4 Earnings, Record Defense Backlog

Technology

Revenue Growth at 85%, Stock Down 48%: The Palantir Valuation Puzzle

Technology

AbbVie Climbs to 52-Week High: Is the Pharma Giant Still Worth Buying?

Life Science

Cathie Wood Snaps Up Three AI Stocks Amid Nasdaq’s Five-Day Selloff

Technology

Tactical Resources to List on Nasdaq via SPAC Merger to Build U.S. Domestic Rare Earth Supply

Mining

South Korea’s Chip Barrage: How Far Can Micron Go?

Technology

OpenAI Reportedly Mulls Delaying IPO to Next Year – Is It Time to Worry About the AI Sector?

Technology

Apple Is the Priciest FAANG by Cash Flow. Who’s the Real Bargain?

Technology

Kymera Jumps on Rapid Eczema Trial Enrollment; Takeover Talk Swirls

Life Science

Apple May Have Finally Found Its Floor

Technology

Merck KGaA’s $11.3 Billion Bio-Techne Buy Bolsters CGT Ambitions in Biggest Deal Since 2014

Life Science

Why Apple’s AI-Fueled Price Shock Doesn’t Break Its Long-Term Investment Case

Consumer Goods, Technology